Building a Smarter Clinical Acne Facial Treatment Approach For Your Practice

Most acne patients who walk into a consultation have already tried something. A cleanser, a topical, possibly a basic facial at a spa down the street. What they have not had is a treatment built around clinical sequencing: the right approach, applied in the right order, for their specific presentation.

The burden of acne vulgaris among adolescents and young adults has increased in nearly all countries since the 1990s, with the age-standardized prevalence rate rising steadily across 204 countries and territories through 2021. Adult presentations are well documented across dermatology clinics, plastic surgery practices, and medical spas, with patients presenting a range of acne types, severity levels, and skin sensitivities that a basic facial was never designed to address.

For practices ready to meet that demand with something more deliberate, the opportunity is real.

Key Takeaways

• Acne-prone skin requires a structured treatment approach that addresses congestion, inflammation, and skin barrier support, not just surface cleansing.
• A professional acne facial is built around clinical sequencing: controlled exfoliation, targeted serum delivery, and anti-inflammatory finishing.
• Microdermabrasion supports pore decongestion and prepares the skin for active ingredient absorption.
• For patients with persistent inflammatory acne, PDL (Pulsed-Dye Laser) therapy and SWT (Selective Waveband Technology) IPL (intense pulsed light)  are FDA-cleared options that address the vascular component of active lesions.
• Practices offering both facial-based management and light-based intervention can serve acne patients across a wider range of presentations.

What Makes Acne-Prone Skin Different to Treat

At its core, acne vulgaris involves four primary pathogenic events: excess sebum production, follicular hyperkeratinization, colonization by Cutibacterium acnes, and the immune-mediated inflammatory response that follows. These factors interact continuously, which is why acne tends to be chronic and recurrent rather than a problem that resolves with a single intervention.

How a patient presents changes what the treatment needs to do. Two distinct patterns show up in practice:

• Comedonal acne (blackheads, whiteheads) reflects follicular blockage without significant bacterial activity. Exfoliation and pore clearing are the primary tools.
• Inflammatory acne (papules, pustules, nodules) involves an active immune response. Surface exfoliation alone does not address the vascular and inflammatory component driving these lesions.

Acne-prone skin also tends to present with a compromised skin barrier and heightened reactivity. Poorly sequenced or overly aggressive treatment can worsen congestion and trigger post-inflammatory changes. A structured, technology-supported approach reduces that risk.

What a Professional Acne Facial Involves

A professional acne facial is not defined by the products in the treatment room. It is by the sequencing logic behind each step and the technology used to execute it. Each step prepares the skin for the next, and removing any one of them compromises the clinical intent of the others.

1. Decongestion and exfoliation begin the sequence. Microdermabrasion removes the outermost layer of dead skin cells through controlled mechanical abrasion and vacuum suction, clearing follicular debris that topical products cannot dislodge on their own. Abrasion depth is adjustable, which matters clinically for acne-prone skin:

• Reactive or sensitive skin warrants a finer tip to avoid worsening the skin's condition
• More pronounced congestion can tolerate greater abrasion without triggering a flare

Diamond-tip microdermabrasion simultaneously exfoliates, extracts debris, and primes the skin for serum penetration, with active ingredients absorbing more readily when pores are open immediately after treatment.

2. Targeted serum delivery follows. Microdermabrasion temporarily reduces the skin's barrier resistance by removing the stratum corneum, which is why timing matters here. Serums containing AHAs, BHAs, or niacinamide reach the skin more effectively at this stage than through standard topical application, supporting oil balance, pore refinement, and surface clarity. What goes in should reflect what the patient presented with, not a fixed formula repeated at every visit.

3. Anti-inflammatory finishing closes the treatment sequence. Extraction and exfoliation leave acne-prone skin in a transiently reactive state, and a calming finish step is where that reactivity gets addressed rather than left unmanaged. Depending on the patient's skin response, this can involve:

• LED therapy to reduce inflammation and support skin recovery post-treatment
• Thermal and cooling applications to bring down visible redness
• A combination of both for patients who present with more pronounced reactivity

Skipping this step sends patients home with the skin more reactive than when they arrived, which undermines both the clinical result and the patient experience.

How to Structure an Acne Facial Approach for Your Practice

Building a professional acne facial into your service offering requires thinking across patient types. Two broad groups show up in practice, and they call for different approaches:

• Comedonal and mildly congested skin responds well to the facial-based approach and is the most likely to return regularly, building the repeat visit rhythm that makes acne facial management a recurring revenue driver
• Persistent or inflammatory presentations sit outside what facial management alone can resolve. The vascular and inflammatory activity driving active lesions requires a step beyond exfoliation and serums.

This is where PDL therapy fits within the clinical framework. PDL targets oxyhemoglobin in the microvasculature of inflammatory acne lesions to a depth of 1 to 1.5mm, reducing the vascular contribution to redness and active lesion formation. PDL at 595 nm reduced inflammatory lesion counts by 49% at 12 weeks, compared to 10% in the control group.

The practice opportunity is not choosing between a facial and a laser. It is having both available so the treatment recommendation matches what the patient actually presents with. All treatment considerations, including session frequency and spacing, remain under the discretion of the qualified licensed healthcare professional.

Supporting Acne-Prone Skin with Glacē^™, Vbeam^®, and Nordlys^®

Two Candela technologies sit at the center of a structured acne treatment offering: Glacē for the facial layer, and Vbeam for inflammatory cases where a facial approach alone is not enough.

• Glacē combines precision microdermabrasion, naturally-derived serum infusion, dual-mode cupping massage, and a calming finishing experience in one compact platform. For acne-prone skin, it is designed to support the full facial sequence in a single session, and integrates alongside energy-based devices to address surface congestion between Vbeam sessions.
• Vbeam is FDA-cleared for inflammatory acne vulgaris. At 595 nm, it addresses the vascular component of active inflammatory lesions directly, reaching the microvasculature at a depth that exfoliation and serums cannot. Variable pulse technology allows practitioners to customize energy delivery based on each patient's skin and lesion type.
• The Nordlys system is FDA cleared and Health Canada licensed that uses Selective Waveband Technology (SWT^®) IPL (PR 530) to address inflammatory acne vulgaris.

Together, Glacē and Vbeam give practices a complete clinical response for acne-prone patients: a facial system for surface management and a laser for the inflammatory cases that need more.

Conclusion: Build an Acne Facial Approach That Works Across Patient Presentations

A well-structured professional acne facial is built on clinical sequencing, not on products alone. Controlled exfoliation, targeted serum delivery at the point of maximum skin receptivity, and a deliberate anti-inflammatory finishing step address the surface and pore-level drivers of acne-prone skin in a way that a standard facial cannot.

When facial management needs reinforcement, PDL provides an FDA-cleared pathway for inflammatory presentations. Practices that offer both are better positioned to serve a wider range of acne presentations and make confident treatment recommendations grounded in clinical rationale.

Contact a Candela product expert to learn how Glacē and Vbeam can support your acne treatment offering.

Frequently Asked Questions

Is microdermabrasion appropriate for patients with active inflammatory acne?

It depends on the presentation. Microdermabrasion works well for comedonal and mildly congested acne, where the goal is clearing blocked follicles and debris from the surface. Running mechanical exfoliation over active papules, pustules, or nodules risks worsening reactivity and spreading bacterial content. When significant inflammatory activity is present, a lighter approach or a shift to light-based intervention is usually the more defensible clinical call.

How often should acne-prone patients return for a professional acne facial?

There is no universal answer because acne varies too much between patients. Someone managing mild, stable congestion will generally benefit from regular appointments spaced to maintain the gains from each session. Someone in an active phase may need more frequent visits initially, then taper as the skin stabilizes. Frequency and spacing are treatment decisions that sit with the qualified licensed healthcare professional managing the patient's care.

At what point should a practice consider adding PDL to an acne facial offering?

The clearest signal is a patient whose inflammatory acne keeps rebounding between facial sessions despite consistent treatment. If active papules, pustules, or persistent redness are showing up at every visit regardless of what the facial addressed the time before, the condition is likely being driven by something deeper than exfoliation and serums can reach. The Vbeam family of devices are FDA-cleared for inflammatory acne vulgaris and give practices a clinically supported option for precisely this patient group.